The tools we use in research should reflect the full spectrum of genetic diversity, but they often do not. This is a gap that an international team of scientists is exploring through the lens of induced pluripotent stem cell (iPSC) lines. iPSCs are a type...
Receiving a heart transplant is a life-changing journey, and you may be wondering about your treatment options. This is why The Heart Hub is excited to introduce A Hearts Journey: A Patient & Caregiver Guide to Heart Transplant. This brand-new, interactive...
On March 5, 2025, The Hospital for Sick Children (SickKids) received a significant breakthrough in pediatric research with an $11.7 million award from Genome Canada. As part of the Canadian Precision Health Initiative, a total of $81 million in...
After eight transformative years at the Ted Rogers Centre for Heart Research (TRCHR), Dr. Soror Sharifpoor is embarking on an exciting new chapter in her career. As the Director of Strategy & Translation at the Translational Biology and Engineering Program (TBEP)...
With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
The Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program, originally launched by the Translational Biology and Engineering Program (TBEP) at the Ted Rogers Centre for Heart Research, was established to help bring cardiovascular innovations to real-world application, and that commitment continues today.
The program has now transitioned to the Temerty Faculty of Medicine, which has assumed operational leadership. Rebranded as the Entrepreneurship for Commercialization of Health Opportunities program, ECHO is now housed within Temerty Medicine’s Commercialization and Partnerships unit. While the program has expanded to include a general health stream, it continues to provide dedicated support for cardiovascular innovation. TBEP remains a key strategic partner in this next phase, contributing to the program’s continued growth and success.
For full program details, eligibility criteria, and application instructions, please visit the new ECHO website.
